Capricor Therapeutics (CAPR) EBITDA Margin Growth (1y) (2012 - 2024)
Capricor Therapeutics (CAPR) EBITDA Margin Growth (1y) (2012 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Capricor Therapeutics |
1.63 Bn |
1.36 Bn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2024 |
-5,020.00 |
| Sep 30, 2024 |
-45,204.00 |
| Jun 30, 2024 |
-9,613.00 |
| Mar 31, 2024 |
16,394.00 |
| Dec 31, 2023 |
79,936.00 |
| Sep 30, 2023 |
29,076.00 |
| Jun 30, 2021 |
469,245.00 |
| Mar 31, 2021 |
-1.16 Mn |
| Dec 31, 2020 |
-660,072.00 |
| Sep 30, 2020 |
-2.20 Mn |
| Jun 30, 2020 |
-652,039.00 |
| Mar 31, 2020 |
-4,632.00 |
| Dec 31, 2019 |
-15,773.00 |
| Sep 30, 2019 |
75,478.00 |
| Jun 30, 2019 |
51,625.00 |
| Mar 31, 2019 |
-16,903.00 |
| Dec 31, 2018 |
-309,106.00 |
| Sep 30, 2018 |
-101,299.00 |
| Jun 30, 2018 |
9,558.00 |
| Mar 31, 2018 |
-49,998.00 |
